Francine Hoffmann

1.1k total citations
16 papers, 793 citations indexed

About

Francine Hoffmann is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Francine Hoffmann has authored 16 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Francine Hoffmann's work include Multiple Sclerosis Research Studies (7 papers), Polyomavirus and related diseases (6 papers) and MicroRNA in disease regulation (5 papers). Francine Hoffmann is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Polyomavirus and related diseases (6 papers) and MicroRNA in disease regulation (5 papers). Francine Hoffmann collaborates with scholars based in Switzerland, Germany and Slovakia. Francine Hoffmann's co-authors include Raija L.P. Lindberg, Ludwig Kappos, Jens Kühle, Matthias Mehling, Claudia Sievers, Paulo Fontoura, David Leppert, Urs Meyer, Lutz Achtnichts and Tobias Derfuß and has published in prestigious journals such as Hepatology, European Journal of Biochemistry and European Journal of Immunology.

In The Last Decade

Francine Hoffmann

16 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francine Hoffmann Switzerland 15 453 335 249 203 121 16 793
Ruize Gao China 8 910 2.0× 329 1.0× 49 0.2× 113 0.6× 91 0.8× 10 1.5k
Vaibhav Singh India 15 266 0.6× 47 0.1× 123 0.5× 86 0.4× 67 0.6× 41 613
Jianan Wang China 19 600 1.3× 272 0.8× 38 0.2× 52 0.3× 117 1.0× 55 926
Carmen Conde Spain 18 431 1.0× 101 0.3× 35 0.1× 312 1.5× 275 2.3× 54 899
Haixing Jiang China 14 211 0.5× 149 0.4× 31 0.1× 181 0.9× 85 0.7× 53 562
Gui Ma China 18 675 1.5× 419 1.3× 49 0.2× 135 0.7× 70 0.6× 35 959
Aitor Etxebarria Spain 15 484 1.1× 123 0.4× 93 0.4× 55 0.3× 76 0.6× 24 874
Nathan Lanning United States 16 530 1.2× 238 0.7× 38 0.2× 178 0.9× 68 0.6× 19 872
Guang‐Nian Zhao China 16 430 0.9× 151 0.5× 38 0.2× 87 0.4× 233 1.9× 24 868
Mingqiang Ren United States 18 586 1.3× 107 0.3× 29 0.1× 127 0.6× 98 0.8× 41 837

Countries citing papers authored by Francine Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Francine Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francine Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francine Hoffmann more than expected).

Fields of papers citing papers by Francine Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francine Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francine Hoffmann. The network helps show where Francine Hoffmann may publish in the future.

Co-authorship network of co-authors of Francine Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Francine Hoffmann. A scholar is included among the top collaborators of Francine Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francine Hoffmann. Francine Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sievers, Claudia, Francine Hoffmann, Tobias Derfuß, et al.. (2019). PARP-1 deregulation in multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(4). 2454314572–2454314572. 16 indexed citations
2.
Sievers, Claudia, Francine Hoffmann, Aiden Haghikia, et al.. (2016). Natalizumab-induced POU2AF1/Spi-B upregulation. Neurology Neuroimmunology & Neuroinflammation. 3(3). e223–e223. 22 indexed citations
3.
Sievers, Claudia, Francine Hoffmann, Tobias Derfuß, et al.. (2014). MiR-126: a novel route for natalizumab action?. Multiple Sclerosis Journal. 20(10). 1363–1370. 33 indexed citations
4.
Sievers, Claudia, Francine Hoffmann, Maria Rasenack, et al.. (2014). Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+T Cells of Patients with Relapsing-Remitting Multiple Sclerosis. Journal of Immunology Research. 2014. 1–11. 45 indexed citations
5.
Sievers, Claudia, et al.. (2012). Altered microRNA expression in B lymphocytes in multiple sclerosis. Clinical Immunology. 144(1). 70–79. 107 indexed citations
6.
Lindberg, Raija L.P., Francine Hoffmann, Matthias Mehling, Jens Kühle, & Ludwig Kappos. (2010). Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients. European Journal of Immunology. 40(3). 888–898. 184 indexed citations
7.
Lindberg, Raija L.P., Lutz Achtnichts, Francine Hoffmann, Jens Kühle, & Ludwig Kappos. (2008). Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. Journal of Neuroimmunology. 194(1-2). 153–164. 85 indexed citations
8.
Kühle, Jens, Raija L.P. Lindberg, Axel Regeniter, et al.. (2007). Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. Journal of Neurology. 254(2). 160–168. 38 indexed citations
9.
Lindberg, Raija L.P., Timo Sorsa, Taina Tervahartiala, et al.. (2006). Gelatinase B [matrix metalloproteinase (MMP)‐9] and collagenases (MMP‐8/‐13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathology and Applied Neurobiology. 32(3). 304–317. 29 indexed citations
10.
Gilli, Francesca, Francine Hoffmann, Arianna Sala, et al.. (2006). Qualitative and quantitative analysis of antibody response against IFNβ in patients with multiple sclerosis. Multiple Sclerosis Journal. 12(6). 738–746. 11 indexed citations
11.
Meyer, Ralf Peter, Raija L.P. Lindberg, Francine Hoffmann, & Urs Meyer. (2005). Cytosolic persistence of mouse brain CYP1A1 in chronic heme deficiency. Biological Chemistry. 386(11). 1157–64. 18 indexed citations
12.
Lindberg, Raija L.P., Corline J.A. De Groot, Ulrich Certa, et al.. (2004). Multiple sclerosis as a generalized CNS disease—comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. Journal of Neuroimmunology. 152(1-2). 154–167. 76 indexed citations
13.
Schuurmans, Macé M., Francine Hoffmann, Raija L.P. Lindberg, & Urs Meyer. (2001). Zinc Mesoporphyrin Represses Induced Hepatic 5–Aminolevulinic Acid Synthase and Reduces Heme Oxygenase Activity in A Mouse Model of Acute Hepatic Porphyria. Hepatology. 33(5). 1217–1222. 14 indexed citations
14.
Jover, Ramiro, et al.. (2000). Limited heme synthesis in porphobilinogen deaminase‐deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital. European Journal of Biochemistry. 267(24). 7128–7137. 50 indexed citations
15.
Scott, Rodney J., Karl Heinimann, Hansjakob Müller, et al.. (1997). Association of Extracolonic Manifestations of Familial Adenomatous Polyposis with Acetylation Phenotype in a Large FAP Kindred. European Journal of Human Genetics. 5(1). 43–49. 14 indexed citations
16.
Graf, Tyler N., Franck Broly, Francine Hoffmann, et al.. (1992). Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers. European Journal of Clinical Pharmacology. 43(4). 399–403. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026